- Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study
- Saponins isolated from roots of Chlorophytum borivilianum reduce acute and chronic inflammation and histone deacetylase
- The regular distribution and expression pattern of immunosuppressive cytokine IL-35 in mouse uterus during early pregnancy
- Peroxisome Proliferator-activated Receptor-γ Agonist Pioglitazone Ameliorates White Matter Lesion and Cognitive Impairment in Hypertensive Rats
- High glucose upregulates CYP24A1 expression which attenuates the ability of 1,25(OH)2D3 to increase NGF secretion in a rat Schwann cell line RSC96
- No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome
- Type III procollagen as a biomarker of susceptibility to ARDS?
- The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy
- Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits
- Sulfiredoxin-1 protects primary cultured astrocytes from ischemia-induced damage
- Acute effects of levosimendan in experimental models of right ventricular hypertrophy and failure
- DNA methylation patterns in newborns exposed to tobacco in utero
- Possible role of serotonin and neuropeptide Y on the disruption of the reproductive axis activity by perfluorooctane sulfonate
- Protective effects of astaxanthin against ischemia/reperfusion induced renal injury in mice
- Versican and its associated molecules: Potential diagnostic markers for multiple myeloma
- Oropharyngeal colostrum administration in extremely premature infants: an RCT.
- Assessment of serum hepcidin levels in patients with non-ST elevation myocardial infarction
- An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease
- Inhibitory effect of somatostatin on insulin secretion is not mediated via the CNS
- The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis
